Bellevue Group AG

Q4 2020 13F Detailed Holdings

Location
Kuesnacht, Switzerland
Holdings as of
12/31/2020
Value ($000)
$8,732,059
Num holdings
266
Date filed
2/16/2021
Form type
13F-HR
Prev filing
11/16/2020
Next filing
5/11/2021
Note
Holdings broken out by “other managers” reported in original SEC filing, see here for holdings aggregated across other managers
Sym Issuer Name Cl CUSIP Value ($000) % Shares Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BB Biotech AG 28-06964
2 Bellevue Asset Management AG 28-16892
3 Bellevue Asset Management (UK) Ltd. 28-20408